NasdaqCM - Delayed Quote • USD
Dyadic International, Inc. (DYAI)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 7:49 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | 1 | 1 | 1 |
| Avg. Estimate | 0 | -0.07 | -0.32 | -0.32 |
| Low Estimate | 0 | -0.07 | -0.32 | -0.32 |
| High Estimate | 0 | -0.07 | -0.32 | -0.32 |
| Year Ago EPS | -0.07 | -0.07 | -0.24 | -0.32 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | 1 | 1 | 1 |
| Avg. Estimate | -- | 1M | 3.5M | 6.1M |
| Low Estimate | -- | 1M | 3.5M | 6.1M |
| High Estimate | -- | 1M | 3.5M | 6.1M |
| Year Ago Sales | -- | 1.3M | 2.9M | 3.5M |
| Sales Growth (year/est) | -- | -23.10% | 20.70% | 74.30% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.08 | -0.05 | -0.06 | -0.06 |
| EPS Actual | -0.07 | -0.07 | -0.06 | -0.08 |
| Difference | 0.01 | -0.02 | 0 | -0.02 |
| Surprise % | 12.50% | -40.00% | 0.00% | -33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | -0.07 | -0.32 | -0.32 |
| 7 Days Ago | 0 | -0.07 | -0.32 | -0.32 |
| 30 Days Ago | 0 | 0 | -0.66 | -0.9 |
| 60 Days Ago | 0 | 0 | -0.66 | -0.9 |
| 90 Days Ago | 0 | 0 | -0.25 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | DYAI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 8.30% |
| Next Qtr. | 0.00% | -- | -- | 10.70% |
| Current Year | -33.30% | -- | -- | 4.90% |
| Next Year | 0.00% | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.23% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/24/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/3/2023 |
| Downgrade | Dawson James: Buy to Neutral | 7/18/2022 |
| Maintains | HC Wainwright & Co.: Buy | 4/5/2022 |
| Initiated | HC Wainwright & Co.: Buy | 12/17/2021 |
Related Tickers
SCNI Scinai Immunotherapeutics Ltd.
2.9700
-25.94%
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
GOVX GeoVax Labs, Inc.
1.6100
-6.40%
KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
FRES Fresh2 Group Limited
0.4375
-5.91%
MBIO Mustang Bio, Inc.
0.1485
-4.19%
FGEN FibroGen, Inc.
1.1000
-7.56%
INM InMed Pharmaceuticals Inc.
0.2354
-7.69%
CNSP CNS Pharmaceuticals, Inc.
5.05
-5.61%
VIRI Virios Therapeutics, Inc.
0.2280
-3.39%